Literature DB >> 1791079

Efficacy and safety of cefotaxime in the management of pediatric infections.

R F Jacobs1.   

Abstract

The utilization of cephalosporins in serious bacterial infections in children has become more widely accepted by pediatric infectious disease specialists over the past five years. The use of cephalosporins has become increasingly popular in empiric antibiotic regimens. The recognition that age-specific bacterial pathogens in neonates, older infants and children can be effectively treated with cephalosporins alone, or in combination with ampicillin, has led to this increasing popularity. This review will discuss the use of cephalosporins in empiric antibiotic regimens and relate the efficacy and safety of specific cephalosporins in the treatment of serious bacterial infections in children.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1791079     DOI: 10.1007/bf01715774

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  32 in total

1.  Reversible ceftriaxone-associated biliary pseudolithiasis in children.

Authors:  U B Schaad; J Wedgwood-Krucko; H Tschaeppeler
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

2.  American Academy of Pediatrics Committee on Infectious Diseases: Treatment of bacterial meningitis.

Authors: 
Journal:  Pediatrics       Date:  1988-06       Impact factor: 7.124

3.  Ceftriaxone-associated cholecystitis.

Authors:  R F Jacobs
Journal:  Pediatr Infect Dis J       Date:  1988-06       Impact factor: 2.129

4.  Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.

Authors:  R N Jones; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

Review 5.  Third generation cephalosporins: safety profiles after 10 years of clinical use.

Authors:  H C Neu
Journal:  J Clin Pharmacol       Date:  1990-05       Impact factor: 3.126

6.  Ceftriaxone effect on bilirubin-albumin binding.

Authors:  S Fink; W Karp; A Robertson
Journal:  Pediatrics       Date:  1987-12       Impact factor: 7.124

Review 7.  Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus.

Authors:  R N Jones
Journal:  Infection       Date:  1985       Impact factor: 3.553

8.  Cefotaxime and desacetylcefotaxime pharmacokinetics in very low birth weight neonates.

Authors:  G L Kearns; R F Jacobs; B R Thomas; T L Darville; J M Trang
Journal:  J Pediatr       Date:  1989-03       Impact factor: 4.406

9.  Ceftriaxone binding to human serum albumin: competition with bilirubin.

Authors:  R Brodersen; A Robertson
Journal:  Mol Pharmacol       Date:  1989-09       Impact factor: 4.436

10.  Therapy of bacterial sepsis and meningitis in infants and children: 1989 poll of directors of programs in pediatric infectious diseases.

Authors:  B M Word; J O Klein
Journal:  Pediatr Infect Dis J       Date:  1989-09       Impact factor: 2.129

View more
  2 in total

1.  Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.

Authors:  Maurice J Ahsman; Enno D Wildschut; Dick Tibboel; Ron A Mathot
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

2.  Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease.

Authors:  Elsa Maksoud; Berengere Koehl; Aude Facchin; Phuong Ha; Wei Zhao; Florentia Kaguelidou; Malika Benkerrou; Patricia Mariani; Albert Faye; Mathie Lorrot; Evelyne Jacqz-Aigrain
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.